SEC Form 4 · accession 0001144204-16-083487
BIOHITECH GLOBAL, INC. · BHTG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert A. Joyce
Officer — President and COO
Period of report
Feb 10, 2016
Accepted (ET)
Feb 19, 2016 · 6:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590383
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory NoteF3,F1,F2 | $3.75 | Feb 10, 2016 | X | 1 | A | Feb 10, 2016 | Feb 10, 2018 | Common Stock | 13,334 | 1 | D |
| WarrantsF5,F3,F4 | $4.50 | Feb 10, 2016 | X | 13,334 | A | Feb 10, 2016 | Feb 10, 2021 | Common Stock | 13,334 | 13,334 | D |
Explanation of responses
- F1Represents the highest possible conversion price of the note.
- F2Represents the number of shares of common stock, par value $0.001 per share (the "Common Stock") into which the note is convertible based on the conversion price of $3.75 per share. The note is convertible into an indeterminable number of shares.
- F3Does not include 301,726 shares of common stock held by the reporting person.
- F4Based upon 120% of the conversion price of $3.75 per share. The warrants are exercisable into an indeterminable number of shares.
- F5Represents the number of shares of Common Stock into which the warrants are exercisable based on the exercise price of $4.50 per share.